/Investor DB

M Ventures — 2023 Investments

5 investments dated 2023 · listed companies and verified rows first · show all

Iktosiktos.aiinMar 2023

Spaya is an AI-powered retrosynthesis platform that identifies synthetic routes to target compounds by converting them into commercially available starting materials.

AI & Machine LearningBiotechDeep TechMedical DevicesParis, FR

Yann(Co-founder and CEO)Quentin(Co-founder and CSO)Nicolas(Co-founder and CTO)Yann Gaston-Mathe(Founder)

Co-investorsDebiopharm Innovation FundOmnes Capital

ImmuneBridgeimmunebridge.comApr 2023 · $12M

ImmuneBridge is a company working in cell-based cancer immunotherapy, including research on engineered natural killer cells for solid tumor treatment.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US

Peretz Partensky(Executive Officer, Director)inStuart Alexander Jacobson(Executive Officer, Director)Nina Horowitz(Chief Executive Officer)inRui Tostoes(Chief Technology Officer)inAlicia Jackson(Director)in

BoardDylan Morris(Director)in

Co-investorsGaingelsLong GameNFXPioneerHealthspan CapitalInsight Partners+2 more

Lightcast Discoverylightcastd.cominAug 2023

Lightcast provides a next-generation single-cell functional analysis platform called Envisia that enables massively parallel profiling of cell-cell interactions and biomolecule secretion at scale.

BiotechDeep TechMedical DevicesCambridge, GB

Co-investorsARCH Venture PartnersIllumina VenturesPerscitus LLP+ND CapitalIllumina InnovationOMX Ventures

Nouscomnouscom.comSeries C · Nov 2023 · $73M

Nouscom is a biotech company whose investors page lists its venture capital backers.

BiotechHealthtech

Riccardo Cortese(Co-Founder)Marina Udier(Chief Executive Officer and Board Director)Elisa Scarselli(Chief Scientific Officer and Co-Founder)Alfredo Nicosia(Co-founder)Antonella Folgori(Co-founder)Stefano Colloca(Co-founder)

Co-investors5AM VenturesAndera PartnersAngelini VenturesRevelation PartnersXGEN VentureBpifrance+6 more

UNISERSunisers.chinSeed · Feb 2023 · $14M

UNISERS develops automated contamination detection systems for semiconductor wafer manufacturing using optical detection and AI algorithms to identify nanoparticles and defect sources, helping chip makers improve production yields.

Advanced ManufacturingAI & Machine LearningDeep TechSemiconductorsZurich, CH

Co-investorsIntel CapitalSwisscom VenturesSICTIC

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.